Logo image of ALKS

ALKERMES PLC (ALKS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ALKS - IE00B56GVS15 - Common Stock

27.98 USD
+0.17 (+0.61%)
Last: 12/31/2025, 8:00:01 PM
28.18 USD
+0.2 (+0.71%)
After Hours: 12/31/2025, 8:00:01 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ALKS. ALKS was compared to 530 industry peers in the Biotechnology industry. ALKS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ALKS has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year ALKS was profitable.
In the past year ALKS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ALKS reported negative net income in multiple years.
In the past 5 years ALKS always reported a positive cash flow from operatings.
ALKS Yearly Net Income VS EBIT VS OCF VS FCFALKS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

The Return On Assets of ALKS (14.57%) is better than 95.28% of its industry peers.
The Return On Equity of ALKS (19.58%) is better than 96.04% of its industry peers.
Looking at the Return On Invested Capital, with a value of 16.22%, ALKS belongs to the top of the industry, outperforming 96.60% of the companies in the same industry.
Industry RankSector Rank
ROA 14.57%
ROE 19.58%
ROIC 16.22%
ROA(3y)8.82%
ROA(5y)3.68%
ROE(3y)13.16%
ROE(5y)4.95%
ROIC(3y)N/A
ROIC(5y)N/A
ALKS Yearly ROA, ROE, ROICALKS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

ALKS's Profit Margin of 22.30% is amongst the best of the industry. ALKS outperforms 94.34% of its industry peers.
Looking at the Operating Margin, with a value of 23.59%, ALKS belongs to the top of the industry, outperforming 95.66% of the companies in the same industry.
With an excellent Gross Margin value of 86.04%, ALKS belongs to the best of the industry, outperforming 88.68% of the companies in the same industry.
ALKS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.59%
PM (TTM) 22.3%
GM 86.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.43%
GM growth 5Y-0.08%
ALKS Yearly Profit, Operating, Gross MarginsALKS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ALKS is creating value.
Compared to 1 year ago, ALKS has less shares outstanding
The number of shares outstanding for ALKS has been increased compared to 5 years ago.
ALKS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALKS Yearly Shares OutstandingALKS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ALKS Yearly Total Debt VS Total AssetsALKS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 5.99 indicates that ALKS is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 5.99, ALKS is doing good in the industry, outperforming 74.53% of the companies in the same industry.
There is no outstanding debt for ALKS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.99
ROIC/WACC2.1
WACC7.71%
ALKS Yearly LT Debt VS Equity VS FCFALKS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 3.67 indicates that ALKS has no problem at all paying its short term obligations.
ALKS has a Current ratio (3.67) which is comparable to the rest of the industry.
A Quick Ratio of 3.27 indicates that ALKS has no problem at all paying its short term obligations.
ALKS has a Quick ratio of 3.27. This is comparable to the rest of the industry: ALKS outperforms 41.70% of its industry peers.
Industry RankSector Rank
Current Ratio 3.67
Quick Ratio 3.27
ALKS Yearly Current Assets VS Current LiabilitesALKS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 19.71% over the past year.
ALKS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.50% yearly.
ALKS shows a small growth in Revenue. In the last year, the Revenue has grown by 1.08%.
ALKS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.87% yearly.
EPS 1Y (TTM)19.71%
EPS 3Y54.92%
EPS 5Y32.5%
EPS Q2Q%-31.94%
Revenue 1Y (TTM)1.08%
Revenue growth 3Y9.89%
Revenue growth 5Y5.87%
Sales Q2Q%4.24%

3.2 Future

Based on estimates for the next years, ALKS will show a decrease in Earnings Per Share. The EPS will decrease by -1.55% on average per year.
Based on estimates for the next years, ALKS will show a small growth in Revenue. The Revenue will grow by 7.72% on average per year.
EPS Next Y-48.04%
EPS Next 2Y-27.54%
EPS Next 3Y-19.2%
EPS Next 5Y-1.55%
Revenue Next Year-2.41%
Revenue Next 2Y10.1%
Revenue Next 3Y6.85%
Revenue Next 5Y7.72%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALKS Yearly Revenue VS EstimatesALKS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
ALKS Yearly EPS VS EstimatesALKS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 2 3 4

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

ALKS is valuated reasonably with a Price/Earnings ratio of 11.28.
Based on the Price/Earnings ratio, ALKS is valued cheaply inside the industry as 97.36% of the companies are valued more expensively.
ALKS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.51.
Based on the Price/Forward Earnings ratio of 18.38, the valuation of ALKS can be described as rather expensive.
ALKS's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALKS is cheaper than 94.53% of the companies in the same industry.
ALKS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.13.
Industry RankSector Rank
PE 11.28
Fwd PE 18.38
ALKS Price Earnings VS Forward Price EarningsALKS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

ALKS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ALKS is cheaper than 97.74% of the companies in the same industry.
98.68% of the companies in the same industry are more expensive than ALKS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.4
EV/EBITDA 7.75
ALKS Per share dataALKS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

ALKS has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as ALKS's earnings are expected to decrease with -19.20% in the coming years.
PEG (NY)N/A
PEG (5Y)0.35
EPS Next 2Y-27.54%
EPS Next 3Y-19.2%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALKS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ALKERMES PLC

NASDAQ:ALKS (12/31/2025, 8:00:01 PM)

After market: 28.18 +0.2 (+0.71%)

27.98

+0.17 (+0.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-28 2025-10-28/bmo
Earnings (Next)02-10 2026-02-10/amc
Inst Owners105.69%
Inst Owner Change8.97%
Ins Owners1.48%
Ins Owner Change-0.34%
Market Cap4.62B
Revenue(TTM)1.52B
Net Income(TTM)339.32M
Analysts80.87
Price Target44.75 (59.94%)
Short Float %12.37%
Short Ratio8.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)66.1%
Min EPS beat(2)59.84%
Max EPS beat(2)72.36%
EPS beat(4)4
Avg EPS beat(4)43.68%
Min EPS beat(4)12.02%
Max EPS beat(4)72.36%
EPS beat(8)4
Avg EPS beat(8)10.27%
EPS beat(12)8
Avg EPS beat(12)42.89%
EPS beat(16)11
Avg EPS beat(16)151.46%
Revenue beat(2)2
Avg Revenue beat(2)10.32%
Min Revenue beat(2)8.51%
Max Revenue beat(2)12.13%
Revenue beat(4)3
Avg Revenue beat(4)7.62%
Min Revenue beat(4)-1.19%
Max Revenue beat(4)12.13%
Revenue beat(8)4
Avg Revenue beat(8)3.11%
Revenue beat(12)7
Avg Revenue beat(12)3.8%
Revenue beat(16)10
Avg Revenue beat(16)3.09%
PT rev (1m)0.72%
PT rev (3m)4.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.27%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)16.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.41%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)3.59%
Valuation
Industry RankSector Rank
PE 11.28
Fwd PE 18.38
P/S 3.04
P/FCF 9.4
P/OCF 8.54
P/B 2.67
P/tB 2.8
EV/EBITDA 7.75
EPS(TTM)2.48
EY8.86%
EPS(NY)1.52
Fwd EY5.44%
FCF(TTM)2.98
FCFY10.63%
OCF(TTM)3.27
OCFY11.7%
SpS9.21
BVpS10.5
TBVpS9.99
PEG (NY)N/A
PEG (5Y)0.35
Graham Number24.2
Profitability
Industry RankSector Rank
ROA 14.57%
ROE 19.58%
ROCE 19.34%
ROIC 16.22%
ROICexc 40.45%
ROICexgc 45.58%
OM 23.59%
PM (TTM) 22.3%
GM 86.04%
FCFM 32.29%
ROA(3y)8.82%
ROA(5y)3.68%
ROE(3y)13.16%
ROE(5y)4.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.43%
GM growth 5Y-0.08%
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 163.07%
Cap/Sales 3.25%
Interest Coverage 250
Cash Conversion 138.93%
Profit Quality 144.77%
Current Ratio 3.67
Quick Ratio 3.27
Altman-Z 5.99
F-Score6
WACC7.71%
ROIC/WACC2.1
Cap/Depr(3y)76.88%
Cap/Depr(5y)63.55%
Cap/Sales(3y)2.83%
Cap/Sales(5y)2.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.71%
EPS 3Y54.92%
EPS 5Y32.5%
EPS Q2Q%-31.94%
EPS Next Y-48.04%
EPS Next 2Y-27.54%
EPS Next 3Y-19.2%
EPS Next 5Y-1.55%
Revenue 1Y (TTM)1.08%
Revenue growth 3Y9.89%
Revenue growth 5Y5.87%
Sales Q2Q%4.24%
Revenue Next Year-2.41%
Revenue Next 2Y10.1%
Revenue Next 3Y6.85%
Revenue Next 5Y7.72%
EBIT growth 1Y-17.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-3.47%
EBIT Next 3Y5.58%
EBIT Next 5Y14.79%
FCF growth 1Y93.4%
FCF growth 3Y76.56%
FCF growth 5YN/A
OCF growth 1Y83.22%
OCF growth 3Y62.84%
OCF growth 5Y43.53%

ALKERMES PLC / ALKS FAQ

What is the fundamental rating for ALKS stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALKS.


What is the valuation status of ALKERMES PLC (ALKS) stock?

ChartMill assigns a valuation rating of 6 / 10 to ALKERMES PLC (ALKS). This can be considered as Fairly Valued.


Can you provide the profitability details for ALKERMES PLC?

ALKERMES PLC (ALKS) has a profitability rating of 7 / 10.


Can you provide the expected EPS growth for ALKS stock?

The Earnings per Share (EPS) of ALKERMES PLC (ALKS) is expected to decline by -48.04% in the next year.